Company intelligence
Colorectal Cancer Alliance
We empower a nation of allies who work with us to provide support for patients and families, caregivers, and survivors.
About Colorectal Cancer Alliance
We are the Colorectal Cancer Alliance — a nation of allies determined to end the second deadliest cancer. Founded in 1999, we are the largest nonprofit dedicated to CRC. We advocate for prevention, magnify patient support, and accelerate research. Join our mission at colorectalcancer.org.
Verified activity
Signals from Colorectal Cancer Alliance
10 published signals
Research & Knowledge
Colorectal Cancer Alliance funded research led by Dr. Alexander Popel at Johns Hopkins to develop an experimental drug designed to destroy colorectal cancer cells.
Reported by Colorectal Cancer Alliance
Capital & Finance
Colorectal Cancer Alliance funded research led by Dr. Alexander Popel at Johns Hopkins to form a company, prepare findings for publication, and work toward a first clinical trial.
Reported by Colorectal Cancer Alliance
Capital & Finance
Colorectal Cancer Alliance funded research led by Dr. Alexander Popel at Johns Hopkins to deliver three trials and land on an elegant solution involving a gel that flows through a syringe and sets the moment it reaches the tumor.
Reported by Colorectal Cancer Alliance
Capital & Finance
Colorectal Cancer Alliance funded research led by Dr. Alexander Popel at Johns Hopkins to build and test new ways to hold the drug in place.
Reported by Colorectal Cancer Alliance
Products & Services
Colorectal Cancer Alliance announced that the Intera 3000™️ HAI Pump, used to deliver HAI therapy, is now made by Boston Scientific and available to patients at hospitals throughout the country.
Reported by Colorectal Cancer Alliance
Research & Knowledge
Colorectal Cancer Alliance funded the development and testing of three new delivery methods for a CRC research team led by Dr. Aleksander S. Popel to address the issue of the drug spilling into healthy tissue.
Reported by Michael Sapienza
Products & Services
Colorectal Cancer Alliance collaborated with the Cologuard team at Abbott on a landing page, direct mail, social media, and press to demystify and inspire people to follow through with colon cancer screening.
Reported by Steven Bushong
Presence & Recognition
Colorectal Cancer Alliance is presenting an educational activity in partnership with PVI and PeerView Institute for Medical Education featuring expert guidance from Tanios Bekaii-Saab, MD on optimizing therapeutic sequencing and integrating innovative regimens for advanced-stage disease management.
Reported by Colorectal Cancer Alliance
Presence & Recognition
Colorectal Cancer Alliance raised more than $61,000 for the Detroit Walk to End Colon Cancer through walkers, volunteers, fundraisers, and supporters.
Reported by Colorectal Cancer Alliance
Products & Services
Colorectal Cancer Alliance partnered with Abbott to launch a new online hub explaining why people may receive a colorectal cancer screening test, what to know before completing it, and when to talk with a healthcare provider.
Reported by Michael Sapienza